Paige, a leader in next-generation AI technology, today announced the release of PRISM2, its most advanced slide-level foundation model to date. PRISM2 is designed to advance large language models (LLM) by enabling them to understand pathology images, connecting visual patterns with…
ChristianaCare and Virtua Health Plan to Co-Found New Regional Nonprofit Health System ChristianaCare and Virtua Health have signed a non-binding letter of intent (LOI) to explore the co-founding of a regional not-for-profit health system. The combined system would provide care across more than…
Hippocratic AI, the global leader and pioneer in generative AI healthcare agents, today announced a partnership with Sheba Medical Center, a global beacon of medical innovation and research ranked by Newsweek as one of the top ten hospitals in the…
Netsmart and the Oregon Council for Behavioral Health (OCBH), a statewide nonprofit association dedicated to ensuring access to quality treatment and care, announced a new program aimed at enhancing behavioral health services through innovative technology across Oregon. Through the OCBH Preferred…
Spear Bio, a biotechnology company pioneering homogeneous ultrasensitive immunoassay technology, is pleased to announce a strategic distribution partnership with Bio-Techne Corporation (NASDAQ: TECH), a global leading provider of innovative reagents, instruments, and solutions for life-science research and clinical diagnostics. The…
The leading provider of technology-enabled radiology services in the U.S., announced today the launch of its new technology services division, Mosaic Clinical Technologies™ and MosaicOS™ a proprietary, radiologist-driven platform designed to address emergent challenges facing the specialty, including rising imaging…
BioAffinity Technologies Receives China Patent for Its Noninvasive Lung Cancer Diagnostic Tool A biotechnology company advancing early-stage cancer diagnostics including CyPath® Lung, the Company’s commercially available test for early-stage lung cancer, today announced it has received notification of allowance from the…
The leading global health technology platform digitising operating rooms (“OR”), announces a partnership with U.S.-based medical technology company, Imperative Care – with the aim of driving the development of a robotic surgical system to treat ischemic stroke. Imperative Care researches, develops and…
Varian, a Siemens Healthineers company, today announced the European launch of IntelliBlate, its next generation microwave ablation solution, for the treatment of soft tissue tumors. Now CE-marked, IntelliBlate represents a pivotal milestone in expanding access to an integrated, intuitive, and…
Aviva Biopharm Reveals Promising Preclinical Results for d3-T, a First-in-Class Women’s Testosterone Therapy, at ENDO 2025 Aviva Biopharm Inc. (Aviva Bio), a clinical-stage biopharmaceutical company developing next-generation hormone therapies for women, announced today that new preclinical data on its lead…
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced an update to their voluntary licensing agreement with the Medicines Patent Pool (MPP) for cabotegravir to include patents relating to its…
Simulations Plus, a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced an investment of $1 million in technology company Nurocor. Founded in 2017, Nurocor offers a cloud-based software platform designed to…
